Phase 1 Manufacturing: How To Prepare
Source: Ascendia Pharma

Phase 1 represents one of the most critical stages of drug development in clinical research because it’s often the first time a drug is tested on human subjects. Despite being smaller in scale, good manufacturing practice (cGMP) requirements must still be followed during Phase 1 to protect the health and safety of trial participants.
This article discusses the lead-up to Phase 1 clinical manufacturing and how drugs are manufactured for clinical research under cGMP.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Ascendia Pharma
This website uses cookies to ensure you get the best experience on our website. Learn more